Fluorinated Chitosan Mediated Synthesis of Copper Selenide Nanoparticles with Enhanced Penetration for Second Near-Infrared Photothermal Therapy of Bladder Cancer

被引:19
作者
Zhang, Shaohua [1 ,2 ]
Li, Guangzhi [1 ]
Deng, Dashi [1 ]
Dai, Yizhi [3 ]
Liu, Zhuang [3 ]
Wu, Song [1 ,4 ,5 ,6 ]
机构
[1] Shenzhen Univ, Affiliated Hosp 3, Dept Urol, Luohu Hosp Grp, Shenzhen 518000, Peoples R China
[2] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Peoples R China
[3] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China
[4] Shantou Univ, Coll Med, Teaching Ctr, Shenzhen Luohu Hosp, Shantou 515000, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510230, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Guangzhou 510230, Peoples R China
基金
中国博士后科学基金;
关键词
bladder cancer; copper selenide nanoparticles; fluorinated chitosan; intravesical instillation; near-infrared-II photothermal therapy; SURFACE-PLASMON RESONANCE; CORE-SHELL NANOPARTICLES; BACILLUS-CALMETTE-GUERIN; PHOTODYNAMIC THERAPY; CU2-XSE NANOPARTICLES; CONVERSION EFFICIENCY; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; CONTRAST AGENTS; NANOCRYSTALS;
D O I
10.1002/adtp.202100043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The emergence of near-infrared-II (NIR-II) light activated photomedicines has extended the penetration depth for noninvasive theranostics, especially for photothermal nanomedicines. Intravesical instillation therapy of bladder cancer (BCa) is restricted greatly due to the short residence time and the low penetration ability of therapeutic agents in clinic. Therefore, improving the mucoadhesiveness and penetration of therapeutic agents are crucial factors in treatment of BCa. The development of NIR-II light triggered photothermal transduction agents for enhanced penetration and photothermal ablation of BCa post-intravesical instillation has not yet been investigated. Herein, Cu2-xSe biocompatible particles are prepared through a fluorinated chitosan (FCS)-mediated one-pot aqueous approach, which possesses enhanced penetrating ability and high photothermal conversion capability for effective NIR-II photothermal therapy (PTT). Owing to the outstanding transmucosal ability of FCS, FCS capped Cu2-xSe nanoparticles exhibit much better transmucosal and penetration performance than their non-fluorinated counterparts to significantly improve the therapeutic efficacy of NIR-II PTT to ablate orthotopic bladder tumors. This study presents a promising phototherapy agent based on Cu2-xSe modified with FCS for efficient NIR-II PTT for BCa treatment post-intravesical instillation.
引用
收藏
页数:12
相关论文
共 84 条
[1]   Photodynamic Therapy of Cancer: An Update [J].
Agostinis, Patrizia ;
Berg, Kristian ;
Cengel, Keith A. ;
Foster, Thomas H. ;
Girotti, Albert W. ;
Gollnick, Sandra O. ;
Hahn, Stephen M. ;
Hamblin, Michael R. ;
Juzeniene, Asta ;
Kessel, David ;
Korbelik, Mladen ;
Moan, Johan ;
Mroz, Pawel ;
Nowis, Dominika ;
Piette, Jacques ;
Wilson, Brian C. ;
Golab, Jakub .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) :250-281
[2]   Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder [J].
Barthelmes, Jan ;
Perera, Glen ;
Hombach, Juliane ;
Duennhaupt, Sarah ;
Bernkop-Schnuerch, Andreas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 416 (01) :339-345
[3]   LASER PHOTODYNAMIC THERAPY FOR BLADDER-CANCER [J].
BENSON, RC .
MAYO CLINIC PROCEEDINGS, 1986, 61 (11) :859-864
[4]   Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study [J].
Berger, AP ;
Steiner, H ;
Stenzl, A ;
Akkad, T ;
Bartsch, G ;
Holtl, L .
UROLOGY, 2003, 61 (02) :338-341
[5]   Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review [J].
Casey, Rowan G. ;
Catto, James W. F. ;
Cheng, Liang ;
Cookson, Michael S. ;
Herr, Harry ;
Shariat, Sharokh ;
Witjes, J. Alfred ;
Black, Peter C. .
EUROPEAN UROLOGY, 2015, 67 (05) :876-888
[6]   International Variations in Bladder Cancer Incidence and Mortality [J].
Chavan, Saurabh ;
Bray, Freddie ;
Lortet-Tieulent, Joannie ;
Goodman, Michael ;
Jemal, Ahmedin .
EUROPEAN UROLOGY, 2014, 66 (01) :59-73
[7]   Advances in nanomaterials for photodynamic therapy applications: Status and challenges [J].
Chen, Jianming ;
Fan, Taojian ;
Xie, Zhongjian ;
Zeng, Qiqiao ;
Xue, Ping ;
Zheng, Tingting ;
Chen, Yun ;
Luo, Xiaoling ;
Zhang, Han .
BIOMATERIALS, 2020, 237
[8]   Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review [J].
Cumberbatch, Marcus G. K. ;
Foerster, Beat ;
Catto, James W. F. ;
Kamat, Ashish M. ;
Kassouf, Wassim ;
Jubber, Ibrahim ;
Shariat, Shahrokh F. ;
Sylvester, Richard J. ;
Gontero, Paolo .
EUROPEAN UROLOGY, 2018, 73 (06) :925-933
[9]   How to Avoid Local Side Effects of Bladder Photodynamic Therapy: Impact of the Fluence Rate [J].
Francois, Aurelie ;
Salvadori, Aurelie ;
Bressenot, Aude ;
Bezdetnaya, Lina ;
Guillemin, Franocis ;
D'Hallewin, Marie Ange .
JOURNAL OF UROLOGY, 2013, 190 (02) :731-736
[10]   Complications Following Radical Cystectomy for Bladder Cancer in the Elderly [J].
Froehner, Michael ;
Brausi, Maurizio A. ;
Herr, Harry W. ;
Muto, Giovanni ;
Studer, Urs E. .
EUROPEAN UROLOGY, 2009, 56 (03) :443-454